rs122456134

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 16P and 4B. PVS1PP5_Very_StrongBS2

The NM_001256789.3(CACNA1F):​c.2872C>T​(p.Arg958*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000557 in 1,077,004 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 21)
Exomes 𝑓: 0.0000056 ( 0 hom. 2 hem. )

Consequence

CACNA1F
NM_001256789.3 stop_gained

Scores

2
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 2.13

Publications

4 publications found
Variant links:
Genes affected
CACNA1F (HGNC:1393): (calcium voltage-gated channel subunit alpha1 F) This gene encodes a multipass transmembrane protein that functions as an alpha-1 subunit of the voltage-dependent calcium channel, which mediates the influx of calcium ions into the cell. The encoded protein forms a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Mutations in this gene can cause X-linked eye disorders, including congenital stationary night blindness type 2A, cone-rod dystropy, and Aland Island eye disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Aug 2013]
CACNA1F Gene-Disease associations (from GenCC):
  • Aland island eye disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • CACNA1F-related retinopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • congenital stationary night blindness 2A
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • X-linked cone-rod dystrophy 3
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant X-49218511-G-A is Pathogenic according to our data. Variant chrX-49218511-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 11615.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAdExome4 at 6 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001256789.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1F
NM_001256789.3
MANE Select
c.2872C>Tp.Arg958*
stop_gained
Exon 24 of 48NP_001243718.1O60840-2
CACNA1F
NM_005183.4
c.2905C>Tp.Arg969*
stop_gained
Exon 24 of 48NP_005174.2O60840-1
CACNA1F
NM_001256790.3
c.2710C>Tp.Arg904*
stop_gained
Exon 24 of 48NP_001243719.1O60840-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1F
ENST00000323022.10
TSL:1 MANE Select
c.2872C>Tp.Arg958*
stop_gained
Exon 24 of 48ENSP00000321618.6O60840-2
CACNA1F
ENST00000376265.2
TSL:1
c.2905C>Tp.Arg969*
stop_gained
Exon 24 of 48ENSP00000365441.2O60840-1
CACNA1F
ENST00000376251.5
TSL:1
c.2710C>Tp.Arg904*
stop_gained
Exon 24 of 48ENSP00000365427.1O60840-4

Frequencies

GnomAD3 genomes
Cov.:
21
GnomAD4 exome
AF:
0.00000557
AC:
6
AN:
1077004
Hom.:
0
Cov.:
33
AF XY:
0.00000571
AC XY:
2
AN XY:
350434
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26018
American (AMR)
AF:
0.00
AC:
0
AN:
31910
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18889
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29334
South Asian (SAS)
AF:
0.00
AC:
0
AN:
51192
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38417
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4085
European-Non Finnish (NFE)
AF:
0.00000721
AC:
6
AN:
831795
Other (OTH)
AF:
0.00
AC:
0
AN:
45364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
21
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Congenital stationary night blindness 2A (2)
2
-
-
not provided (2)
1
-
-
CACNA1F-related disorder (1)
1
-
-
Congenital stationary night blindness (1)
1
-
-
Retinal dystrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.74
D
BayesDel_noAF
Pathogenic
0.60
CADD
Pathogenic
38
DANN
Uncertain
1.0
FATHMM_MKL
Uncertain
0.91
D
PhyloP100
2.1
Vest4
0.84
GERP RS
4.7
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.26
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.26
Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs122456134; hg19: chrX-49074970; COSMIC: COSV100544544; COSMIC: COSV100544544; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.